Possible protective function of Rh factor in schizophrenia;Možná protektivní funkce Rh faktoru u schizofrenie

Psychiatrie

Volumn 15, Issue SUPPL. 2, 2011, Pages 38-43

  Holub, David ^a,c   Motlová, Lucie Bankovská ^a,b,c   Dragomirecká, Eva ^b,c   Rodriguez, Mabel ^b   Preiss, Marek ^b,c   Novák, Tomáš ^b,c   Čermák, Jan ^b,c   Libiger, Jan ^a,d   Flegr, Jaroslav ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^c FCentrum Neuropsychiatrických Studií   (Czech Republic)

^d Psychiatrická Klinika Fakultní Nemocnice Hradec Králové   (Czech Republic)

Author keywords

Latent toxoplasmosis; Protective factors; Rh factor; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; RHESUS ANTIGEN;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PERCEPTION DISORDER; PHENOTYPE; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; SCHIZOPHRENIA; SEROLOGY; SEX DIFFERENCE; TOXOPLASMOSIS;

EID: 84856090629     PISSN: 12117579     EISSN: 12126845     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bankovská Motlová L, Dragomirecká E, Čermák J, Holub D. Frekvence relapsůa kvalita života absolventů denního stacionáře pro terapii psychóz: Výsledky ročního sledování. Psychiatrie 2010; 14 (Suppl. 2): 73-76.
2. Biver S, Scohy S, Szpirer J, Szpirer C, Andre B, Marini AM. 2006: Physiological role of the putative ammonium transporter RhCG in the mouse. Transfus Clin Biol 13: 167-168. (Pubitemid 44313841)
3. British National Formulary. British National Formulary number 59. 2010. London: British Medical Association and Royal Pharmaceutical Society of Great Britain.
4. Fekadu A, Shibre T, Cleare AJ. 2010. Toxoplasmosis as a cause for behaviour disorders - overview of evidence and mechanisms. Folia Parasitol 57:105-113.
5. Flegr J, Zitková S, Kodym P, Frynta D. 1996. Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology 113:49-54. (Pubitemid 26228367)
6. Flegr J, Havlíček J, Kodym P, Malý M, Smahel Z (2002). Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect Dis 2; art-11.
7. Flegr J. 2007. Effects of Toxoplasma on human behaviour. Schizophr Bull 33:757-760.
8. Flegr J., Novotná M, Lindová, J, Havlíček J. 2008. Neurophysiological effect of the Rh factor. Protective role of the RhD molecule against Toxoplasma-induced impairment of reaction times in women. Neuroendocrinol Lett 29, 475-481.
9. Flegr J, Klose J, Novotná M, Berenreitterová M, Havlíček J. 2009. Increased incidence of traffic accidents in Toxoplasma-infected military drivers and protective effect RhD molecule revealed by a large-scale prospective cohort study. BMC Infect Dis 9: e72.
10. Flegr J, Novotná M, Fialová A, Kolbeková P, Gašová Z. 2010a. The influence of RhD phenotype on toxoplasmosis- and age-associated changes in personality profile of blood donors. Folia Parasitol 57:143-150.
11. Flegr J. 2010b. Influence of latent toxoplasmosis on the phenotype of intermediate hosts. Folia Parasitol 57:81-87.
12. Holub D, Motlová L, Rodriguez M, Preiss M, Čermák J, Libiger J. 2006a. Toxoplasma gondii u schizofrenie. [(Toxoplasma gondii in Schizophrenia.) (In Czech with English abstract)] Psychiatrie 10(2):81-87. (Pubitemid 44034097)
13. Holub D, Motlová L, Rodriguez M, Dragomirecká E, Preiss M, Čermák J, Ungrmanová M, Nechutná R, Kaňková S. Postnatal latent toxoplasmosis in schizophrenia: Cognitive and psychopathological Correlates. Psychiatrie 2006b; 10 (Suppl 3): 66-70. (Pubitemid 44580153)
14. Hung GBK. 2007. A Comparison of two methods for calculating total antipsychotic dose. Hong Kong J Psychiatr 17:87-90. (Pubitemid 350099873)
15. Israelski DM, Remington JS. 1988. Toxoplasmic encephalitis in patients with AIDS. Infect Dis Clin North Am 2:429-445.
16. Kaňková Š, Šulc J, Flegr J. 2010. Increased pregnancy weight gain in women with latent toxoplasmosis and RhD-positivity protection against this effect. Parasitology.
17. Kay SR, Fiszbein A, Opler LA. 1987. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13:261-275.
18. Kodym P, Malý M, Švandová E, et al. 2001. Toxoplasmosis in the Czech Republic 1923 - 1999: First case to widespread outbreak. Int J Parasitol 31:125-132.
19. Kodym P, Machala L, Roháčová H, Š irocká B, Malý M. 2007. Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis. Clin Microbiol Infect 13:40-47. (Pubitemid 44869206)
20. 2 channels. Transfus Clin Biol 13: 103-110.
21. Leweke FM, Gerth CW, Koethe D, Klosterkötter J, Ruslanova I, Krivogorsky B et al. 2004. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 254:4-8. (Pubitemid 39310542)
22. Lindenmayer JP, Grochowski S, Hyman RB. 1995. Five-factor model of schizophrenia: replication across samples. Schizophr Res 14:229-234.
23. Lindová J, Novotná M, Havlíček J et al. 2006. Gender differences in behavioural changes induced by latent toxoplasmosis. Int J Parasitol 36:1485-1492. (Pubitemid 44751745)
24. Lindová J, Kuběna AA, Šturcová A, Křivohlavá R, Novotná M, Rubešová A, Havlíček J, Kodym P, Flegr J. 2010. Pattern of money allocation in experimental games supports the stress hypothesis of gender differences in Toxoplasma gondii-induced behavioural changes. Folia Parasitol 57:136-142.
25. Montoya JG, Liesenfeld O. 2004. Toxoplasmosis. Lancet 363(9425):1965-1976. (Pubitemid 38759657)
26. Novotná M, Havlíček J, Smith AP, Kolbeková P, Skallová A, Klose J, Gašová, Z, Písačka M, Sechovská M, Flegr J. 2008. Toxoplasma and reaction time: Role of toxoplasmosis in the origin, preservation and geographical distribution of Rh blood group polymorphism. Parasitology, 135:1253-1261.
27. Torrey EF, Yolken RH. 2003. Toxoplasma gondii and schizophrenia. Emerg Infect Diseases 9:1375-1380. (Pubitemid 37356208)
28. van der Gaag M, Cuijpers A, Hoffman T, et al. 2006a. The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophr Res 85:273-279. (Pubitemid 43947548)
29. van der Gaag M, Hoffman T, Remijsen M, et al. 2006b. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revise model. Schizophr Res 85:273-279. (Pubitemid 43947548)
30. Westhoff CM. 2007. The Structure and Function of the Rh antigen Complex. Semin Hematol 44(1):42-50. (Pubitemid 46013923)